[{"NetIncomeLoss_1_Q2_USD":14400000.0,"AssetsCurrent_0_Q2_USD":1085700000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":98800000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-200000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":600000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-2800000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":477500000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":477500000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":37900000.0,"ProceedsFromSaleOfShortTermInvestments_2_Q2_USD":170700000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-3600000.0,"InventoryFinishedGoods_0_Q2_USD":32800000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":98800000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":1600000.0,"ProvisionForDoubtfulAccounts_1_Q2_USD":2000000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":2600000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":80600000.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":274000000.0,"AccruedExchangeFeeRebateCurrentAndNoncurrent_0_Q2_USD":10300000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":154900000.0,"DeferredFinanceCostsNet_0_Q2_USD":18300000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":477500000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ShareBasedCompensation_2_Q2_USD":13700000.0,"Assets_0_Q2_USD":1626700000.0,"CommonStockSharesIssued_0_Q2_shares":65604347.0,"InterestExpenseDebtExcludingAmortization_1_Q2_USD":2200000.0,"InterestExpenseDebtExcludingAmortization_2_Q2_USD":4300000.0,"AccruedSalariesCurrent_0_Q2_USD":32600000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":5100000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":11300000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":8213284.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":8256475.0,"SellingAndMarketingExpense_1_Q2_USD":80800000.0,"SellingAndMarketingExpense_2_Q2_USD":164700000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":83800000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ProductWarrantyAccrual_0_Q2_USD":8100000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-400000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":400000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":-2900000.0,"CommonStockValue_0_Q2_USD":100000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":3000000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":2500000.0,"AccountsReceivableNetCurrent_0_Q2_USD":78000000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":1000000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":64970187.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":65578513.0,"InterestAndDividendIncomeOperating_1_Q2_USD":700000.0,"InterestAndDividendIncomeOperating_2_Q2_USD":2200000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":2200000.0,"EarningsPerShareBasic_1_Q2_USD":0.22,"EarningsPerShareBasic_2_Q2_USD":0.19,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":11200000.0,"InventoryRawMaterials_0_Q2_USD":33700000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":34200000.0,"InterestCostsCapitalizedAdjustment_2_Q2_USD":3200000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":14000000.0,"InterestCostsCapitalizedAdjustment_1_Q2_USD":1600000.0,"CapitalizedContractCostNet_0_Q2_USD":29600000.0,"CapitalizedContractCostAmortization_1_Q2_USD":2600000.0,"CapitalizedContractCostAmortization_2_Q2_USD":5100000.0,"Liabilities_0_Q2_USD":1063400000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":779100000.0,"AllowanceForDoubtfulAccountsReceivableRecoveries_1_Q2_USD":100000.0,"AllowanceForDoubtfulAccountsReceivableRecoveries_2_Q2_USD":200000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":700000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":1500000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":14600000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":9900000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q2_USD":-1600000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_2_Q2_USD":-26800000.0,"IncreaseDecreaseInInventories_2_Q2_USD":2800000.0,"ProductWarrantyAccrualPayments_1_Q2_USD":2900000.0,"ProductWarrantyAccrualPayments_2_Q2_USD":5600000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":464900000.0,"RevenueRemainingPerformanceObligation_0_Q2_USD":5900000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":18800000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":69700000.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":226300000.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_1_Q2_pure":0.172,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_2_Q2_pure":0.17,"AccountsPayableCurrent_0_Q2_USD":35600000.0,"LiabilitiesCurrent_0_Q2_USD":134400000.0,"InventoryWorkInProcess_0_Q2_USD":37200000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":64370791.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":63627231.0,"InterestExpense_2_Q2_USD":23400000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":22800000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5800000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":26800000.0,"InterestIncomeExpenseNet_2_Q2_USD":-21200000.0,"InterestIncomeExpenseNet_1_Q2_USD":-11100000.0,"Goodwill_0_Q2_USD":39600000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":0.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":200000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":13700000.0,"InterestExpense_1_Q2_USD":11800000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":779100000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":59600000.0,"NetIncomeLoss_2_Q2_USD":12300000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":423200000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":4500000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DeferredCostsAndOtherAssets_0_Q2_USD":43800000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":10900000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":2900000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":2900000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":500000.0,"AdditionalPaidInCapital_0_Q2_USD":1227600000.0,"GrossProfit_1_Q2_USD":142500000.0,"GrossProfit_2_Q2_USD":269400000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":42300000.0,"LongTermDebtNoncurrent_0_Q2_USD":910200000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":779100000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":14200000.0,"CapitalizedContractCostNetNoncurrent_0_Q2_USD":19700000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-2400000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":1200000.0,"AmortizationOfFinancingCosts_1_Q2_USD":700000.0,"AmortizationOfFinancingCosts_2_Q2_USD":1400000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":20900000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":5800000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":13700000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1626700000.0,"PreferredStockValue_0_Q2_USD":0.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":22100000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":5000000.0,"InventoryNet_0_Q2_USD":103700000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":65300000.0,"ProductWarrantyAccrualWarrantiesIssued_1_Q2_USD":2700000.0,"ProductWarrantyAccrualWarrantiesIssued_2_Q2_USD":5200000.0,"AccountsPayableTradeCurrent_0_Q2_USD":4700000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":17400000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":14800000.0,"OperatingIncomeLoss_1_Q2_USD":27500000.0,"OperatingIncomeLoss_2_Q2_USD":35000000.0,"AmortizationOfDebtDiscountPremium_1_Q2_USD":10500000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":424300000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":1300000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_2_Q2_USD":3100000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q2_USD":100000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":1600000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":1100000.0,"EarningsPerShareDiluted_1_Q2_USD":0.22,"EarningsPerShareDiluted_2_Q2_USD":0.19,"CommonStockSharesOutstanding_0_Q2_shares":65604347.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":565400000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-660800000.0,"CapitalizedContractCostNetCurrent_0_Q2_USD":9900000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":22300000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-2400000.0,"LongTermInvestments_0_Q2_USD":23500000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":4600000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":51700000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":900000.0,"StockholdersEquity_0_Q2_USD":563300000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q2_USD":1600000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":18800000.0,"UnbilledReceivablesCurrent_0_Q2_USD":22300000.0,"Ticker":"PODD","CIK":"1145197","name":"INSULET CORP","OfficialName":"Insulet Corporation Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"18774052057.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20200807"}]